Blue Horseshoe Stocks: Momentum Plays & More

Medbox, Inc. MDBX

MDBX is a stock that we were tracking fairly heavily over the course of the fall season, awaiting a solid bottom-bounce signal as the stock drew back steadily in PPS over a period of many weeks.

Yesterday we were sent into high alert mode with regard to MDBX, and while the observation came just a few minutes late to make it into our premarket report, it was shared in our trader’s chat promptly at the open as you can see from the following snapshot:

What ensued was an intraday run, and the strong bounce signal we were awaiting all along. From a low of .02 MDBX shot up 95% to reach an HOD of .039; that worked out to a 95% pop.

We felt it was another perfect illustration of why we encourage all of our followers to get in on our daily trader’s chats. There are often opportunities mentioned that won’t appear in our premarket reports, appearing in the chatroom throughout the course of a given day.

Once again, all one needs to do is log onto a Skype account and send a contact request to username ‘stocksumo‘, and you will be admitted into the chat!


pSivida Corp. PSDV – News Alert

We’re casting a portion of our attention this morning in the direction of PSDV. As we were examining this morning’s PR feeds, we noticed an announcement from the company referring to positive Phase-III study data and a huge concurring gap-up.

Medidur is PSDV’s treatment in development for an eye affliction known as posterior uveitis, and the results of the trials are said to be “statistically significant”. We’ll be monitoring this play as the session kicks off today in the event that the move up on the chart is significant as well.

Given that it’s traded up over 50% in today’s premarket, we may need to observe for possible dip-and-rip action in the stock.


Extended Watchlist:
NXGA, TALK, BLTA, LTNC, KWBT

Blue Horseshoe Stocks: Potential Bottom-Plays & More

Solaris Power Cells, Inc. SPCL

We’ve got a news play hitting our scanner this morning in SPCL, and as it turns out, the chart is looking ripe for a nice move. As we’ve pointed out on the following snapshot, the stock is trading near a relative bottom, having just registered a new 52-week low just two weeks ago.

Our regular readers are well acquainted with our history of banking excellent gains off a good rebound play. SPCL could be next in line on that front, so we’ll keep a sharp eye on it to start the week.

In addition to trading near a bottom, we’re seeing signs of a very oversold stock with a lot of room to the upside:

PALM SPRINGS, Calif., July 13, 2015 (GLOBE NEWSWIRE) — Solaris Power Cells, Inc. the creators of the Solaris PESATM “Passive Electron Storage Array”™, (the “Company”) (OTCQB:SPCL)  the Board of Directors of Solaris Power Cells today announced the appointment of long-time energy policy leader Robert Foster to lead Solaris Energy Storage Advisory Board, effective July 10th 2015. >> FULL PR


OncoGenex Pharmaceuticals, Inc OGXI

OGXI announced this morning that one of its cancer treatments, currently in Phase III trials has passed rigorous criteria and
that trials for patients with non-small cell lung cancer will proceed as planned. The stock is gapping up in premarket trading, and we’re going to monitor its activity as the session commences.

BOTHELL, Wash. and VANCOUVER, British Columbia, July 13, 2015 /PRNewswire/ — OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) announced today that its Phase 3 ENSPIRIT trial evaluating custirsen in the treatment of advanced or metastatic non-small cell lung cancer (NSCLC) is continuing as planned per the recommendation of an Independent Data Monitoring Committee>> FULL PR



Frontline, Ltd. FRO

We’ve got a long history with FRO that stretches all the way back to 2012. We tagged FRO in Thursday’s premarket report, after it hit a relative bottom of 2.21 on Wednesday. Our observed low following Thursday’s alert was 2.32, and on Friday we saw as the stock inched up to a high of 2.43. We’re going to be on the lookout for further gains; the stock is gapping up slightly in early trading this morning.

An added element to the story is an opinion article that came across the wires last week pertaining to the perceived undervaluation of FRO. It points to a potential longer-term uptrend in the cards, stating that while this year’s earnings growth is expected to top last year’s by more than 200%, that hasn’t really been reflected in the share price. We suggest our subscribers click the following link and give it a read >> VIEW ARTICLE


Extended Watchlist:
PSDV, GILT, FREE, GRPN, DANG, CLTX, DRYS

CBIS, OLIE, BGMD & Extended Watchlist

Cannabis Science Inc.  CBIS

CBIS is among the medical marijuana cast of characters that we’ve been following for a very long time. We began tracking this play almost two years ago, and have certainly seen a fair bit of dips and rips during that time. Freshest in our minds would be our alerts from this past February, at which point we witnessed huge gains as CBIS rose from the .04-range all way up to .1195.

We decided that now was as good a time as any to re-alert this play, as we’ve noticed it coming off of its 52-week low at .0299. At this time of year, it’s common to see stocks being subjected to tax-loss selling. We want to be on our guard as this period winds down, when selling pressure is likely to be alleviated. Stocks like CBIS stand to gain ground when that happens, as we head into 2014.


Olie, Inc. OLIE

OLIE turned out to be a well-timed call for us from yesterday. The stock may have ended the session in the red, but not before running from .0082 all the way up to a high of .02! That was good for an intraday mega-move of 147% on almost ten times the 3mo. average volume.

As we said, there was a significant pullback into the close at .0097, and with the kind of volatility we’re seeing out of OLIE, we definitely want to pay attention heading into week’s end. Further opportunities could certainly present themselves.


BG Medicine, Inc. BGMD

We had BGMD in yesterday’s extended watchlist, as we were tracking its pullback off of a recent spike. We did in fact get the bounce that we were looking for; following its morning low of .87, the stock would go on to hit a high of 1.05. A strong close at 1.04 suggests that momentum could carry over, and indeed we are seeing the stock gapping up in pre-market trading today.


Extended Watchlist:
ALIM, PERI, PSDV, OXBT, CDTI, TSEM, GILT